Industry: Healthcare | Publish Date: 14-Apr-2025 | No of Pages: 156 | No. of Tables: 120 | No. of Figures: 65 | Format: PDF | Report Code : HC1259
Trump Tariffs Are Reshaping Global Business
The Canada Dialysis Market size was valued at USD 3.96 billion in 2023, and is expected to reach USD 5.08 billion by 2030, with a CAGR of 3.6% from 2024 to 2030.
Canada dialysis market is a segment of the healthcare sector focused on providing artificial kidney functions to individuals with impaired renal function. Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.
This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.
The escalating healthcare expenditure is a pivotal driver for the Canada dialysis market, fostering increased investments in renal care infrastructure. As countries allocate substantial resources to enhance their healthcare systems, the expansion of dialysis services becomes a focal point.
This augmented financial commitment translates into improved accessibility to dialysis facilities, upgraded medical equipment, and enhanced patient care. The growing healthcare expenditure underscores a collective effort to address the rising prevalence of kidney-related ailments, further propelling the demand for dialysis treatments and positively impacting the overall market dynamics.
The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD).
With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.
The Canada dialysis market faces a substantial restraint in the form of elevated treatment costs. The expenses associated with dialysis procedures, including equipment, facilities, and skilled healthcare professionals, contribute to a financial burden on both patients and healthcare systems. This high cost of dialysis can impede accessibility to treatment, particularly for individuals with limited financial resources thereby constraining the market expansion.
The emergence of wearable and portable dialysis devices stands as a groundbreaking advancement in dialysis technology, offering a transformative opportunity for the dialysis market. These compact systems, resembling small backpacks, empower patients with unprecedented mobility and flexibility in their treatment schedules.
For instance, AWAK Technologies (AWAK), an innovative medical technology firm specializing in dialysis using regenerative technology for end-stage renal disease, revealed that the U.S. Food and Drug Administration (FDA) conferred the breakthrough device designation upon its AWAK Peritoneal Dialysis (AWAK PD) device.
This device, which is both wearable and highly portable, incorporates AWAK's patented sorbent technology. As technology continues to advance, we can anticipate further innovations in dialysis technology, ultimately leading to even better outcomes for patients.
Several market players operating in the Canada dialysis market include NephroCan, Fresenius, Baxter Canada, Nipro Canada, Nikkiso Co. Ltd., B. Braun Avitum AG, Sinai Health, Georgian Bay General Hospital, Scarborough Health Network, Renfrew Victoria Hospital, Pembroke Regional Hospital, Lakeridge Health, Soldiers’ Memorial Hospital, Interior Health, The Ottawa Hospital, and others.
Hemodialysis
Conventional Hemodialysis
Hemofiltration
On-line Hemodiafiltration
Off-line Hemodiafiltration
Peritoneal Dialysis
Conventional Dialysis
Short Daily Dialysis
Nocturnal Dialysis
Equipment
Dialysis Machines
Dialyzers
Bloodlines
Other Equipment
Consumables
Dialysis Fluids
Catheters
Dialysis Access Devices
Other Consumables
Services
Dialysis Treatment Services
Maintenance and Support Services
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
NephroCan
Fresenius
Baxter Canada
Nipro Canada
Nikkiso Co. Ltd.
B. Braun Avitum AG
Sinai Health
Georgian Bay General Hospital
Scarborough Health Network
Renfrew Victoria Hospital
Pembroke Regional Hospital
Lakeridge Health
Soldiers’ Memorial Hospital
Interior Health
The Ottawa Hospital
Parameters |
Details |
Market Size in 2023 |
USD 3.96 Billion |
Revenue Forecast in 2030 |
USD 5.08 Billion |
Growth Rate |
CAGR of 3.6% from 2024 to 2030 |
Analysis Period |
2023–2030 |
Base Year Considered |
2023 |
Forecast Period |
2024–2030 |
Market Size Estimation |
Billion (USD) |
Growth Factors |
|
Companies Profiled |
15 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |